Romero-Gómez, M. Et Al. 2023. A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease. Journal of Hepatology , vol.79, no.4 , 888-897.

Romero-Gómez, M., Lawitz, E., Shankar, R. R., Chaudhri, E., Liu, J., Lam, R. L., ... Kaufman, K. D.(2023). A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease. Journal of Hepatology , vol.79, no.4, 888-897.

Romero-Gómez, Manuel Et Al. "A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease," Journal of Hepatology , vol.79, no.4, 888-897, 2023

Romero-Gómez, Manuel Et Al. "A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease." Journal of Hepatology , vol.79, no.4, pp.888-897, 2023

Romero-Gómez, M. Et Al. (2023) . "A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease." Journal of Hepatology , vol.79, no.4, pp.888-897.

@article{article, author={Manuel Romero-Gómez Et Al. }, title={A phase IIa active-comparator-controlled study to evaluate the efficacy and safety of efinopegdutide in patients with non-alcoholic fatty liver disease}, journal={Journal of Hepatology}, year=2023, pages={888-897} }